This inventor holds 3 USPTO granted patents and 9 published patent applications and 2 EPO patents. Top assignees: Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Flag Chemical Industry Co., Ltd.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: The Innovations of Dan Xu
Introduction
Dan Xu is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of AKT inhibitors. With a total of 3 patents to his name, Xu's work is recognized for its potential impact on medical treatments.
Latest Patents
Among his latest patents is a unit dosage composition of an AKT inhibitor. This pharmaceutical composition is designed in unit dosage form and includes a compound of formula I-0 or a pharmaceutically acceptable salt thereof. The mass of the compound I-0 or its salt ranges from 5 mg to 400 mg calculated as free base. Additionally, Xu has developed an AKT inhibitor that specifically relates to a compound represented by formula I or a pharmaceutically acceptable salt thereof. This invention also provides a preparation method and its use in the prevention and/or treatment of diseases mediated by AKT protein kinase.
Career Highlights
Dan Xu has worked with prominent companies in the pharmaceutical industry, including Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. and Jiangsu Flag Chemical Industry Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, Xu has collaborated with various professionals, including Changyou Ma and Jian Wu. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Dan Xu's contributions to the field of pharmaceuticals, particularly through his patents on AKT inhibitors, highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile